Memorandum from NZSG
Posted Thursday April 6, 2023
The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website.
Gallery
Related Articles
NZSG-NZgNC Annual Scientific Meeting Call for Abstracts Now Open
Tuesday May 20, 2025
Abstract submissions are now open and close at 5pm on Friday 8 August 2025.
Pharmac Consultation: Proposal to fully fund liquid nutrition replacements for adults with Crohn's disease requiring EEN
Sunday May 18, 2025
Please consider submitting your feedback as an individual or as a joint submission between the gastroenterology and the ...
IBD Research Review Issue 70
Tuesday May 13, 2025
Read about the latest IBD research and upcoming conferences.